Published in PLoS One on December 13, 2013
A hostel for the hostile: the bone marrow niche in hematologic neoplasms. Haematologica (2015) 0.99
Metabolomics in rheumatic diseases: desperately seeking biomarkers. Nat Rev Rheumatol (2016) 0.88
Profiling of serum metabolites in canine lymphoma using gas chromatography mass spectrometry. J Vet Med Sci (2014) 0.85
Identification of drug combinations containing imatinib for treatment of BCR-ABL+ leukemias. PLoS One (2014) 0.81
Starving cancer from the outside and inside: separate and combined effects of calorie restriction and autophagy inhibition on Ras-driven tumors. Cancer Metab (2016) 0.78
A scalable method for molecular network reconstruction identifies properties of targets and mutations in acute myeloid leukemia. J Comput Biol (2015) 0.78
Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia. Proteome Sci (2014) 0.78
Serum metabonomics of acute leukemia using nuclear magnetic resonance spectroscopy. Sci Rep (2016) 0.77
Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia. J Hematol Oncol (2016) 0.75
Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis. RMD Open (2016) 0.75
Modeling The Bone Marrow Microenvironment's Influence on Leukemic Disease. Transl Biomed (2016) 0.75
Pushing CT and MR imaging to the molecular level for studying the "omics": current challenges and advancements. Biomed Res Int (2014) 0.75
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A (2007) 15.88
Regulation of cancer cell metabolism. Nat Rev Cancer (2011) 15.44
ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics (2006) 14.49
Reverse engineering of regulatory networks in human B cells. Nat Genet (2005) 13.16
Cancer cell metabolism: Warburg and beyond. Cell (2008) 11.80
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature (2012) 10.39
HMDB 3.0--The Human Metabolome Database in 2013. Nucleic Acids Res (2012) 9.21
Statin use and reduced cancer-related mortality. N Engl J Med (2012) 8.51
Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature (2006) 8.16
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature (2012) 8.13
Mutual information relevance networks: functional genomic clustering using pairwise entropy measurements. Pac Symp Biocomput (2000) 8.02
Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev (2008) 7.87
Acute lymphoblastic leukemia. N Engl J Med (2004) 7.83
Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov (2011) 5.79
The human serum metabolome. PLoS One (2011) 5.55
Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res (2010) 4.14
Lipid metabolism in cancer. FEBS J (2012) 3.42
Serum-free cell culture: a unifying approach. Cell (1980) 3.41
minet: A R/Bioconductor package for inferring large transcriptional networks using mutual information. BMC Bioinformatics (2008) 3.15
Clinical applications of metabolomics in oncology: a review. Clin Cancer Res (2009) 2.91
Choline metabolism in malignant transformation. Nat Rev Cancer (2011) 2.85
Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med (2012) 2.60
Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol (2005) 2.10
The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Respir Crit Care Med (2011) 2.02
Normal structure, function, and histology of the bone marrow. Toxicol Pathol (2006) 1.92
Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia. Blood (2011) 1.88
Asparagine synthetase chemotherapy. Annu Rev Biochem (2006) 1.82
Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia (2009) 1.77
American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays. J Clin Oncol (2011) 1.71
Early detection of recurrent breast cancer using metabolite profiling. Cancer Res (2010) 1.61
Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy. Anal Biochem (2008) 1.51
Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia (2009) 1.50
Comparing statistical methods for constructing large scale gene networks. PLoS One (2012) 1.49
Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. Leukemia (2010) 1.41
The oncoprotein H-RasV12 increases mitochondrial metabolism. Mol Cancer (2007) 1.33
Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia. Int J Nanomedicine (2006) 1.28
MetaboLab--advanced NMR data processing and analysis for metabolomics. BMC Bioinformatics (2011) 1.27
Uniformity in sensitivity test media. J Antimicrob Chemother (1978) 1.22
Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961). Anticancer Res (2004) 1.04
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity. Leukemia (2010) 1.03
Profiling metabolic networks to study cancer metabolism. Curr Opin Biotechnol (2012) 1.02
Hypoxia triggers major metabolic changes in AML cells without altering indomethacin-induced TCA cycle deregulation. ACS Chem Biol (2010) 1.01
Evaluation of methods for trace-element determination with emphasis on their usability in the clinical routine laboratory. Scand J Clin Lab Invest (2007) 0.99
Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity. Blood (2010) 0.96
L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment. Cancer Chemother Pharmacol (2003) 0.84
Changes of amino acid serum levels in pediatric patients with higher-risk acute lymphoblastic leukemia (CCG-1961). In Vivo (2004) 0.83
The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97). Haematologica (2011) 0.82
Identification of drug combinations containing imatinib for treatment of BCR-ABL+ leukemias. PLoS One (2014) 0.81
Combinations of Kinase Inhibitors Protecting Myoblasts against Hypoxia. PLoS One (2015) 0.75
Evolutionary and Topological Properties of Genes and Community Structures in Human Gene Regulatory Networks. PLoS Comput Biol (2016) 0.75